1. Home
  2. MDXH vs KOPN Comparison

MDXH vs KOPN Comparison

Compare MDXH & KOPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDXH
  • KOPN
  • Stock Information
  • Founded
  • MDXH 2003
  • KOPN 1984
  • Country
  • MDXH Belgium
  • KOPN United States
  • Employees
  • MDXH N/A
  • KOPN N/A
  • Industry
  • MDXH
  • KOPN Semiconductors
  • Sector
  • MDXH
  • KOPN Technology
  • Exchange
  • MDXH Nasdaq
  • KOPN Nasdaq
  • Market Cap
  • MDXH 93.1M
  • KOPN 85.7M
  • IPO Year
  • MDXH 2021
  • KOPN 1992
  • Fundamental
  • Price
  • MDXH $1.96
  • KOPN $1.22
  • Analyst Decision
  • MDXH Strong Buy
  • KOPN Strong Buy
  • Analyst Count
  • MDXH 2
  • KOPN 4
  • Target Price
  • MDXH $7.00
  • KOPN $2.50
  • AVG Volume (30 Days)
  • MDXH 145.0K
  • KOPN 2.4M
  • Earning Date
  • MDXH 02-26-2025
  • KOPN 03-13-2025
  • Dividend Yield
  • MDXH N/A
  • KOPN N/A
  • EPS Growth
  • MDXH N/A
  • KOPN N/A
  • EPS
  • MDXH N/A
  • KOPN N/A
  • Revenue
  • MDXH $84,708,000.00
  • KOPN $44,266,305.00
  • Revenue This Year
  • MDXH $27.57
  • KOPN $21.40
  • Revenue Next Year
  • MDXH $20.09
  • KOPN $14.05
  • P/E Ratio
  • MDXH N/A
  • KOPN N/A
  • Revenue Growth
  • MDXH 33.01
  • KOPN 0.60
  • 52 Week Low
  • MDXH $1.55
  • KOPN $0.56
  • 52 Week High
  • MDXH $4.44
  • KOPN $2.82
  • Technical
  • Relative Strength Index (RSI)
  • MDXH 38.10
  • KOPN 48.11
  • Support Level
  • MDXH $1.97
  • KOPN $1.18
  • Resistance Level
  • MDXH $2.25
  • KOPN $1.27
  • Average True Range (ATR)
  • MDXH 0.16
  • KOPN 0.14
  • MACD
  • MDXH -0.04
  • KOPN -0.04
  • Stochastic Oscillator
  • MDXH 0.00
  • KOPN 26.92

About MDXH MDxHealth SA

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA), and Europe.

About KOPN Kopin Corporation

Kopin Corp is a provider of high-performance application-specific optical solutions consisting of high-resolution microdisplays and optics, subassemblies, and headsets. It serves soldiers, avionics, armored vehicles training and simulation military applications, and others. Its product portfolio includes Microdisplays, Spatial Light Modulators, Optical Modules, Medical, Training, and Simulation. Geographically, it derives a majority of its revenue from the Americas and also has a presence in Asia-Pacific; Europe, and Other Countries.

Share on Social Networks: